Publications by authors named "M L Espinoza"
Chronic Pain-A Global Problem Demanding Local Evidence and Guidelines.
Value Health Reg Issues
December 2024
How can managed entry agreements contribute to coverage decisions in Latin America?
Int J Technol Assess Health Care
December 2024
Context: Healthcare stakeholders in Latin America, including payers, manufacturers, and patients, seek to expedite access to technologies. However, uncertainty sometimes surrounds their true benefits and budgetary implications. Managed entry agreements (MEAs) are proposed to address this uncertainty by redistributing risks among key actors.
View Article and Find Full Text PDFUrban flooding is a pervasive global risk, posing a great challenge to urban planners, policymakers, and particularly communities. This paper reviews the literature to analyze how urban flooding is defined across scientific disciplines. Our objectives are to uncover the elements used to define urban flooding and evaluate how these elements can impact future research and practice.
View Article and Find Full Text PDFBackground: Chile has made significant progress in recent decades in implementing policies to improve the efficiency of its health system with an impact on population health.
Aim: To present five case studies of successful policies whose impact has been documented.
Methods: Case study report.
Article Synopsis
- - Biosimilars can greatly improve access to biologic treatments in Latin America, but their adoption is hindered by misunderstandings, regulatory issues, and insufficient monitoring of their use.
- - A panel of experts recommended enhancing regulations, improving transparency, establishing solid monitoring systems, and fostering collaboration among various stakeholders to better educate about the benefits of biosimilars.
- - To successfully integrate biosimilars and their interchangeability, Latin American countries need to close knowledge gaps and biases among healthcare providers and patients, which can be achieved through effective communication and real-world evidence.